Immunoglobulin Light Chain Amyloidosis
📧 Sign up to get email alerts when something new happens for Immunoglobulin Light Chain Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis [Phase 3]
A Phase 3 trial reports that probiotic supplementation reduces GI symptoms during therapy and improves therapeutic response in immunoglobuli…
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis [Phase 4]
A Phase 4 trial comparing BTD and BCD regimens for Immunoglobulin Light-Chain Amyloidosis.
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: Bortezomib for Immunoglobulin Light Chain(AL) Amyloidosis
A clinical trial evaluating bortezomib for immunoglobulin light chain (AL) amyloidosis has completed.